Back
Discover Financial Services Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
59
DFS
Discover Financial Services
Last Price:
127.04
Seasonality Move:
8.42%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Buy
59
Discover Financial Services (DFS)
is a Buy
Is Discover Financial Services a Buy, Sell or Hold?
- The current Discover Financial Services [DFS] share price is $126.97. The Score for DFS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- DFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DFS Stock Price Chart
What is Discover Financial Services's stock price today?
-
The Discover Financial Services share price today is $126.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DFS is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
DFS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.61 | Buy |
Relative Strength Index (14 RSI): | 57.75 | Buy |
Chaikin Money Flow: | -177649 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.86 - 125.68) | Buy |
Bollinger Bands (100): | (115.73 - 127.85) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | 722527 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.99 - 42.29) | Sell |
Bollinger Bands (100): | (41.03 - 48.83) | Sell |
DFS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 124.64 | Buy |
20-day SMA: | 123.5 | Buy |
50-day SMA: | 124.2 | Buy |
200-day SMA: | 108.13 | Buy |
8-day EMA: | 125.46 | Buy |
20-day EMA: | 124.42 | Buy |
50-day EMA: | 123.6 | Buy |
200-day EMA: | 114.19 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.38 | Sell |
20-day SMA: | 40.41 | Sell |
50-day SMA: | 41.94 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.76 | Sell |
20-day EMA: | 40.54 | Sell |
50-day EMA: | 42.03 | Sell |
200-day EMA: | 43.46 | Sell |
Discover Financial Services Earnings Growth & DFS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.17 per share, and an increase next year of $1.74 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Discover Financial Services Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |